Twin Tree Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Twin Tree Management's IBB Position: Q3 2026 in Review
Twin Tree Management sold out of iShares Biotechnology ETF (IBB) in Q3 2026, closing a stake of 11,620 shares — an estimated $2.21M sold.
Twin Tree Management first reported a position in IBB in Q4 2016 and held it in 16 quarters. The position peaked at $52.3M in Q2 2021. 798 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Twin Tree Management reported no remaining iShares Biotechnology ETF position as of Q3 2026 after selling out during the quarter.
- Twin Tree Management sold 11,620 iShares Biotechnology ETF shares in Q3 2026, an estimated $2.21M.
- Twin Tree Management first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 16 quarters.
- Twin Tree Management's iShares Biotechnology ETF position peaked at $52.3M in Q2 2021.
- 798 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Twin Tree Management's 13F filing for Q3 2026, filed 10 Nov 2026.